Medicare Enrolled
Dr. Kenneth Smith, MD
Internal Medicine · Chesterfield, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Smith from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Smith?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Smith
Dr. Kenneth Smith is an internal medicine specialist in Chesterfield, MI, with 21 years of NPI registration. Based on federal Medicare data, Dr. Smith performed 2,762 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Smith received a total of $10,518 from 52 pharmaceutical and/or device companies across 705 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Smith is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 7% volume in MI
$10,518 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,762
Medicare services
Top 7% in MI for internal medicine
Not available
Unique patients (not deduplicated)
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,080 | $18 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
440 | $44 | $176 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
438 | $7 | $9 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
185 | $46 | $200 |
| Annual depression screening | 155 | $18 | $30 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
90 | $9 | $44 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
87 | $10 | $37 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $25 | $122 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
64 | $31 | $45 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
60 | $72 | $75 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
37 | $51 | $113 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
19 | $42 | $93 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
15 | $2 | $4 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
12 | $56 | $440 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,518
Total received (2018-2024)
Avg $1,503/year across 7 years
Top 8% in MI for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
705
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,857
2023
$1,189
2022
$1,320
2021
$1,382
2020
$487
2019
$1,834
2018
$2,449
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$362
Lilly USA, LLC
$232
Novo Nordisk Inc
$224
Exact Sciences Corporation
$212
Amgen Inc.
$164
ABBVIE INC.
$150
PFIZER INC.
$130
GlaxoSmithKline, LLC.
$96
Boehringer Ingelheim Pharmaceuticals, Inc.
$86
Xeris Pharmaceuticals, Inc.
$41
Astellas Pharma US Inc
$40
Merck Sharp & Dohme LLC
$34
Sumitomo Pharma America, Inc.
$27
Abbott Laboratories
$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 44.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,200
AstraZeneca Pharmaceuticals LP
$1,046
Boehringer Ingelheim Pharmaceuticals, Inc.
$927
PFIZER INC.
$907
Lilly USA, LLC
$753
Amgen Inc.
$655
GlaxoSmithKline, LLC.
$425
SANOFI-AVENTIS U.S. LLC
$424
Merck Sharp & Dohme Corporation
$373
Exact Sciences Corporation
$341
ABBVIE INC.
$329
Astellas Pharma US Inc
$301
Janssen Pharmaceuticals, Inc
$301
Novartis Pharmaceuticals Corporation
$285
Corcept Therapeutics
$213
AbbVie Inc.
$158
Sunovion Pharmaceuticals Inc.
$152
Teva Pharmaceuticals USA, Inc.
$124
DePuy Synthes Sales Inc.
$122
Bayer Healthcare Pharmaceuticals Inc.
$107
Bayer HealthCare Pharmaceuticals Inc.
$104
Abbott Laboratories
$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$91
Amarin Pharma Inc.
$90
E.R. Squibb & Sons, L.L.C.
$72
Allergan Inc.
$71
Baxter Healthcare
$67
AbbVie, Inc.
$60
IDORSIA PHARMACEUTICALS US INC
$56
Grifols USA, LLC
$55
ARBOR PHARMACEUTICALS, INC.
$53
Merck Sharp & Dohme LLC
$52
Kowa Pharmaceuticals America, Inc.
$47
Nestle HealthCare Nutrition Inc.
$46
Avanir Pharmaceuticals, Inc.
$43
Xeris Pharmaceuticals, Inc.
$41
Currax Pharmaceuticals LLC
$41
NESTLE HEALTHCARE NUTRITION INC.
$36
Arbor Pharmaceuticals, Inc.
$32
Sumitomo Pharma America, Inc.
$27
Alkermes, Inc.
$23
Advanced Respiratory, Inc
$22
Insulet Corporation
$19
Boston Scientific Corporation
$18
Biohaven Pharmaceutical Holding Company Ltd.
$15
Insmed, Inc.
$15
Radius Health, Inc.
$14
Sanofi Pasteur Inc.
$14
Circassia Pharmaceuticals Inc
$14
Eisai Inc.
$14
Biohaven Pharmaceuticals, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$14
Top 3 companies account for 30.2% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AIRSUPRA · AJOVY · AMYVID · ANORO · ANORO ELLIPTA · AUSTEDO · Aimovig · Arikayce · BME NITINOL CONTINUOUS COMPRESSION IMPLANTS · BREO · BREZTRI · BYDUREON · BYSTOLIC · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · Cologuard Collection Kit · Creon · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL · GARDASIL 9 · GEMTESA · GVOKE HYPOPEN · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LINZESS · LONHALA MAGNAIR · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NUEDEXTA · NURTEC ODT · Omnipod · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRADAXA · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolastin-C Liquid · Prolia · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SEEBRI · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · Tresiba · Tymlos · UBRELVY · Utibron · VESICARE · VIAGRA · VIVITROL · VRAYLAR · Vascepa · Veozah · Victoza · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZENPEP
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
1,103
County median income
$76,399
Nearest hospital to ZIP centroid (approximate)
HARBOR OAKS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Smith is a clinical cardiology specialist, with above-average Medicare volume (top 7% in MI), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Smith experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Smith performed 1,080 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Smith receive payments from pharmaceutical companies?
Yes. Dr. Smith received a total of $10,518 from 52 companies across 705 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Smith's costs compare to other internal medicine physicians in Chesterfield?
Dr. Smith's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Smith) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Chesterfield
Browse internal medicine physicians in Chesterfield ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in MI
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in MI
Which MI internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology